Quell Therapeutics Announces Presentation at Oppenheimer's 32nd Annual Healthcare Conference

/PRNewswire/ -- Quell Therapeutics Ltd ("Quell"), a world leader in the development of engineered T-regulatory (Treg) cell therapies for serious medical...

Related Keywords

Boston ,Massachusetts ,United States ,London ,City Of ,United Kingdom ,Eleanor Perkin ,Frazer Hall ,Luke Henry ,Christina Tartaglia ,Therapeutics Ltd ,Quell Therapeutics Ltd ,Annual Oppenheimer Healthcare Conference ,Chief Business ,Mark Swallow ,Quell Therapeutics ,